Global corruption remains alarmingly high, according to the 2024 Corruption Perceptions Index (CPI) released today by ...
The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...
A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.
LEXINGTON, Mass. - Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology firm focused on neurogenetic medicines with a market capitalization of $290 million, announced today it is reassessing its ...
A well-known bar owner was recently diagnosed with ALS and the community is rallying together to help support him and his family.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results